Combining the science of emotional trauma with concrete psychological techniques- including dream interpretation, journaling, mindfulness exercises, and meditation-Shulman's frank and empathetic account will help readers regain their emotional balance by navigating the passage from profound sorrow to healing and growth.
Recent innovations, including deep brain stimulation and new medications, have significantly improved the lives of people with Parkinson’s disease. Nevertheless, medical, emotional, and physical challenges remain. The second edition of this accessible and comprehensive guide provides crucial information for managing this complex condition, including details on the use of medications, diet, exercise, complementary therapies, and surgery. The second edition includes new information about: • The genetic and hereditary pattern of the disease • Medications and uses of established medications • Other approaches to treating the symptoms of Parkinson’s • Juvenile-onset Parkinson’s disease • Normal pressure hydrocephalus • The effects of fluctuating hormones on disease symptoms • Fetal cell transplants and porcine cell transplants • The nutritional supplement Co-Enzyme Q10
Recent innovations, including deep brain stimulation and new medications, have significantly improved the lives of people who have Parkinson's disease. Nevertheless, patients and families continue to face many challenges. This book is suitable for reliable advice about medical, emotional, and physical issues.
Significant advancements in understanding Parkinson's disease have emerged over the past five years, particularly regarding the effects of MPTP and the potential for transplantation therapies. In January 1988, a research meeting organized by the National Parkinson Foundation in Key Biscayne, Florida, aimed to foster collaboration among scientists in the field. The published proceedings document current findings, focusing on clinical and neuropathological insights, particularly concerning dopaminergic neurons and the biology of dopamine receptors.